Press "Enter" to skip to content

‘Terrible dilemma’: Toobin on FDA’s Alzheimer treatment approval

CNN’s Jeffrey Toobin weighs in on the FDA’s approval of a new Alzheimer’s drug in June despite the FDA’s advisory committee concluding there wasn’t enough evidence to support the effectiveness of the treatment.

CNN’s Jeffrey Toobin weighs in on the FDA’s approval of a new Alzheimer’s drug in June despite the FDA’s advisory committee concluding there wasn’t enough evidence to support the effectiveness of the treatment.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *